November 2025: Transforming Cancer Care with Wearables

Wearable implant delivering continuous, personalized cancer therapy for everyday life.

Image credits: OptoBio

We are excited to introduce the SOMA system from OptoBio, a next-generation wearable and implantable solution designed to transform the way we treat cancer. Sleek, discreet, and built for everyday life, SOMA merges minimally-invasive implant technology with a wearable over-ear module, offering continuous, bioelectronic therapy without interrupting your routine.

Unlike treatments that tie you to hospital stays or scheduled infusions, SOMA brings targeted care directly into your daily life. With a discreet implant the size of a shirt button, ultrathin bio-threads, and an over-ear wearable that powers and monitors the system, you can receive precision therapy while remaining present in the moment.

Seamlessly integrated with the SOMA app and clinician interface, the system enables real-time data sharing, personalized adjustments, and continuous monitoring. Whether at home, at work, or on the go, it provides freedom, style, and advanced therapy without compromise.

About SOMA

Created to enhance human wellbeing through wearable and implantable healthcare technology, the SOMA system fuses design and intelligence into one seamless experience. By bringing advanced neuro-electronic and bioanalytic features into everyday therapy, OptoBio redefine how we treat, monitor, and live with cancer.

Sam Draper
November 4, 2025

November 2025

Innovation of the Month

Do you want to discover more, visit the website
Visit Website

Other news

Dexcom Receives FDA Clearance for its Real-Time API Integration with Third-Party Apps and Devices

DexCom, the global leader in real-time continuous glucose monitoring (CGM) for people with ...

Digital Mask to Protect Patients’ Privacy

It will prevent patients’ sensitive personal biometric information from being extracted and shared.

Fertility Tracking App Flo Raises $50M Series B Round, Bringing Company Valuation to $800M

Fertility tracking app Flo announced it closed $50M in a Series B financing, bringing the total ...

February 2022: SoftPulse™ by Datwyler

Our Innovation of the Month enables the next generation of brain-monitoring devices: SoftPulse™
Discover more